These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 2793383)
1. Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine. Earhart RH; Khandekar JD; Faraggi D; Schinella RA; Davis TE Invest New Drugs; 1989 Jul; 7(2-3):255-60. PubMed ID: 2793383 [TBL] [Abstract][Full Text] [Related]
2. Phase II study of acivicin in colorectal carcinoma: a National Cancer Institute of Canada study. Maroun JA; Fields AL; Pater JL; Stewart DJ; Cripps C; Eisenhauer E Cancer Treat Rep; 1984 Sep; 68(9):1121-3. PubMed ID: 6478451 [TBL] [Abstract][Full Text] [Related]
3. Phase II trial of acivicin in patients with advanced epithelial ovarian carcinoma. A Gynecologic Oncology Group Study. McGuire WP; Blessing JA; DiSaia PJ; Buchsbaum HJ Invest New Drugs; 1986; 4(1):49-52. PubMed ID: 3700040 [TBL] [Abstract][Full Text] [Related]
4. Phase II study of acivicin as a 72-hr continuous infusion in patients with untreated colorectal cancer. A National Cancer Institute of Canada Clinical Trials Group Study. Eisenhauer EA; Maroun JA; Fields AL; Walde PL Invest New Drugs; 1987 Dec; 5(4):375-8. PubMed ID: 3436743 [TBL] [Abstract][Full Text] [Related]
5. Phase II trial of acivicin in patients with advanced colorectal carcinoma. Adolphson CC; Ajani JA; Stroehlein JR; Barlogie B; Bodey GP; Korinek J; Bedikian AY Am J Clin Oncol; 1986 Jun; 9(3):189-91. PubMed ID: 3728371 [TBL] [Abstract][Full Text] [Related]
6. Phase II trial of acivicin in advanced breast carcinoma: a Cancer and Leukemia Group B Study. Booth BW; Korzun AH; Weiss RB; Ellison RR; Budman D; Khojasteh A; Wood W Cancer Treat Rep; 1986 Oct; 70(10):1247-8. PubMed ID: 3530455 [No Abstract] [Full Text] [Related]
7. Phase I-II trial of acivicin in adult acute leukemia. Powell BL; Craig JB; Capizzi RL; Richards F Invest New Drugs; 1988 Apr; 6(1):41-4. PubMed ID: 3165971 [TBL] [Abstract][Full Text] [Related]
8. Phase II trials of 5-day vinblastine infusion (NSC 49842), L-alanosine (NSC 153353), acivicin (NSC 163501), and aminothiadiazole (NSC 4728) in patients with recurrent or metastatic renal cell carcinoma. Elson PJ; Kvols LK; Vogl SE; Glover DJ; Hahn RG; Trump DL; Carbone PP; Earle JD; Davis TE Invest New Drugs; 1988 Jun; 6(2):97-103. PubMed ID: 3170135 [TBL] [Abstract][Full Text] [Related]
9. Phase I trial and pharmacokinetics of acivicin administered by 72-hour infusion. Earhart RH; Koeller JM; Davis TE; Borden EC; McGovren JP; Davis HL; Tormey DC Cancer Treat Rep; 1983; 67(7-8):683-92. PubMed ID: 6871883 [TBL] [Abstract][Full Text] [Related]
10. Phase II clinical trial of acivicin in advanced breast cancer: an Eastern Cooperative Oncology Group Study. Willson JK; Knuiman MW; Skeel RT; Wolter JM; Pandya KJ; Falkson G; Chang YC Cancer Treat Rep; 1986 Oct; 70(10):1237-8. PubMed ID: 3530452 [No Abstract] [Full Text] [Related]
11. Phase II evaluation of acivicin in lung cancer: a Southeastern Cancer Study Group Trial. Kramer BS; Birch R; Greco A; Prestridge K; Johnson R Cancer Treat Rep; 1986 Aug; 70(8):1031-2. PubMed ID: 3524833 [No Abstract] [Full Text] [Related]
12. Phase II study of acivicin in non-small cell lung cancer: a National Cancer Institute of Canada Study. Maroun JA; Maksymiuk A; Eisenhauer E; Stewart DJ; Young V; Pater J Cancer Treat Rep; 1986 Nov; 70(11):1327-8. PubMed ID: 3021326 [TBL] [Abstract][Full Text] [Related]
13. Phase II study of 96-hr continuous-infusion etoposide and doxorubicin with bolus cyclophosphamide in refractory epithelial ovarian cancer. Fleming GF; Waggoner SE; Rotmensch J; Skoog LA; Langhauser C Gynecol Oncol; 1997 Apr; 65(1):42-5. PubMed ID: 9103389 [TBL] [Abstract][Full Text] [Related]
14. Phase II trial of piperazinedione (NSC 135758) in the treatment of advanced or recurrent carcinoma of the ovary. A Gynecologic Oncology Group study. Thigpen JT; Blessing JA; Arseneau JC; Homesley HD Am J Clin Oncol; 1984 Jun; 7(3):261-3. PubMed ID: 6547268 [TBL] [Abstract][Full Text] [Related]
15. A randomized phase II study of acivicin and 4'deoxydoxorubicin in patients with hepatocellular carcinoma in an Eastern Cooperative Oncology Group study. Falkson G; Cnaan A; Simson IW; Dayal Y; Falkson H; Smith TJ; Haller DG Am J Clin Oncol; 1990 Dec; 13(6):510-5. PubMed ID: 2173394 [TBL] [Abstract][Full Text] [Related]
16. Phase II trial of vinblastine in previously treated patients with ovarian cancer: a Southwest Oncology Group Study. Surwit EA; Alberts DS; O'Toole RV; Graham V; Hannigan EV; Stephens RL; Boutselis JG Gynecol Oncol; 1987 Sep; 28(1):14-9. PubMed ID: 3653765 [TBL] [Abstract][Full Text] [Related]
17. Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomas. Earhart RH; Amato DJ; Chang AY; Borden EC; Shiraki M; Dowd ME; Comis RL; Davis TE; Smith TJ Invest New Drugs; 1990 Feb; 8(1):113-9. PubMed ID: 2188926 [TBL] [Abstract][Full Text] [Related]
18. Phase I evaluation of AT-125 single dose every three weeks. Taylor S; Belt RJ; Joseph U; Haas CD; Hoogstraten B Invest New Drugs; 1984; 2(3):311-4. PubMed ID: 6511237 [TBL] [Abstract][Full Text] [Related]
19. Phase II evaluation of aclacinomycin-A in advanced ovarian carcinoma. Martino S; Decker DA; Hynes HE; Kresge CL Invest New Drugs; 1987 Dec; 5(4):373-4. PubMed ID: 3481362 [TBL] [Abstract][Full Text] [Related]
20. Phase I study of acivicin in patients with advanced cancer. Sridhar KS; Ohnuma T; Chahinian AP; Holland JF Cancer Treat Rep; 1983; 67(7-8):701-3. PubMed ID: 6871885 [No Abstract] [Full Text] [Related] [Next] [New Search]